Sid Senroy and his company RegDev, Inc. have helped with the regulatory approval of drugs with more than $ 30 billion in annual sales Senroy Joins Contakt World Board of Directors as Special Advisor to CVO Justin Beck and as Business Advisor for International Markets RegDev is committed to providing COVID-19 test kits for a seamless testing solution , tracing and case management via Smart Health RM – SaaS from Contakt World…
- Sid Senroy and his firm RegDev, Inc. (“RegDev“) have helped regulatory approval of drugs with over $ 30 billion in annual sales
- Mr. Senroy joins the Contakt World Board of Directors as Special Advisor to CVO Justin Beck and as Business Advisor for International Markets
- RegDev Pledged to Provide COVID-19 Test Kits for Transparent Testing, Tracing, and Case Management Solution via Smart Health RM – Contakt World’s SaaS Solution
Contakt World Technologies Corp. (CSE: HELP) (OTC: TLOOF) (FSE: B2I) (the “Company” or “Contakt World”) is pleased to announce the retention of biotechnology and pharmaceutical leader Sid Senroy as a member of its board of administration. Directors, as Special Advisor to Chief Visionary Officer (“CVO”) Justin Beck, and as Commercial Advisor for International Markets. The principal regulatory affairs and compliance firm owned by Mr. Senroy, RegDev, has also been retained by Contakt World to develop supply chains for disease testing.
Justin Beck, CVO and Founder of Contakt World, commented, “We are honored that Mr. Senroy, an icon and visionary who has helped gain regulatory approval for pharmaceuticals with over $ 30 billion in annual sales, joins us in several ways. In addition to his service on our Board of Directors, I will work closely with Mr. Senroy to develop channels for our products and services, and towards innovation for Contakt World that solves challenges for humanity.
Mr Senroy added: “I think Contakt World is developing something special, from its team to its SaaS platform, RM smart health. I look forward to applying my personal experience, as well as my team at RegDev, to accelerate and realize our business plans. The need for better testing has never been more evident than during the pandemic. Our success could save lives.
INTEGRATED DISEASE TESTING AND SUPPLY CHAIN
Contakt World engaged RegDev to source from multiple COVID-19 test kit vendors with an integrated view of disease testing, contact tracing, case management and case tracking via RM smart health. With transparent test kit sales and results for disease cases, Contakt World customers will be able to isolate cases without unnecessary administrative steps and silos of disparate data that have resulted in countless deaths around the world. . While RegDev’s initial commitment centers around COVID-19 test kits, the Company intends to use these initial relationships with vendors aligned by RegDev as a springboard for further disease testing integrated into RM smart health.
After screening for the disease, the offer and the results are integrated into RM smart health, Contakt World will be positioned to link testing to strain sequencing, which will help the world understand the variants and factors influencing the course and morphology of contagions. All of these steps aim to provide public and private markets with a unique capacity to cope with the epidemic of any disease, which Contakt World sees as the key to a successful health infrastructure. Mr Beck added, “If we can buy and ship a package anywhere in the world in a matter of days as a company, we can successfully find and trace cases of illness. We have to be bold and we cannot be satisfied with the way things have worked. We are trying to forever disrupt the way we find, track and monitor cases of disease. “
Mr. Senroy is a leader in the global biotechnology and pharmaceutical industry with an MBA from Pepperdine University. His expertise is in helping companies pass compliance assessments, develop robust quality systems, and prepare for reviews and inspections by global health authorities.
As President and Founder of RegDev, a global drug development consultancy focused on compliance and regulatory processes, he has helped small and large public and private pharmaceutical companies achieve their goals, including supporting drug inspections. biological research monitoring and over 30 successful NDA / BLA. Submissions / Review / Approvals leading to over US $ 30 billion in annual sales for these products.
In connection with the retention of consultants, officers and directors, Contakt World issued a total of 1,530,000 RSUs and 4,200,000 stock options at an exercise price of $ 0.58 .
The Company received the resignation of Catherine Delcin, Esq. as a director of the board, and the consent of Siddhartha Senroy to join the board. The Company would like to thank Ms. Delcin for her exceptional service to the Company. Ms. Delcin will continue as an employee of the Company.
The Company also announces the appointment of Diana Mark as Corporate Secretary, and that it has moved its head office and registered office to 6204-125e Street, Surrey, BC V3X 2E1.
CEO and Interim Director
About Contakt World
World Contact is a technology company that develops and delivers SaaS solutions for the public and private sectors. The company integrates data collection and management, communications, advertising and IoT devices, providing customers with a scalable ecosystem that makes sense of people, place, time and space for the emerging world ‘phygital ”(Physical and digital mixture). Contakt World is committed to improving health equity and disease management while solving industry-specific business challenges.
For more information, please visit the Company’s website at www.contakt.world.
Certain information contained in this press release contains statements that reflect “forward-looking information” as that term is defined in Canadian securities laws (“forward-looking statementsThese forward-looking statements are often identified by words such as “intends”, “anticipates”, “expects”, “believes”, “anticipates”, “likely” or similar words. More Specifically, this press release contains forward-looking statements regarding the appointment of Mr. Senroy, the Company’s agreement with RegDev and the Company’s future business plans. Forward-looking statements reflect management’s expectations, estimates or projections. of Contakt World regarding future results or events, based on opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Contakt World believes that the expectations reflected in the forward-looking statements are reasonable , forward-looking statements involve risks and uncertainties and one should not place undue reliance on forward-looking statements because unknown or unforeseeable factors could cause actual results to differ from those reflected in forward-looking statements. Forward-looking statements may also be affected by risks and uncertainties relating to Contakt World’s business, including those described in the Company’s public documents available at www.SEDAR.com. The Company assumes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved of the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90716